today announced that the U.S. Foodand DrugAdministration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
The Ministry of Food and Drug Safety held the 6th Cosmetics Day celebration with the Korea Cosmetics Association today (17th).Under the slogan "K-Cosmetics, ...